|
SCRN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.39050000022867E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62536650805123E-12 |
| Stage1-vs-Stage2 |
1.165550E-01 |
| Stage1-vs-Stage3 |
2.958400E-02 |
| Stage1-vs-Stage4 |
3.903400E-03 |
| Stage2-vs-Stage3 |
3.716700E-03 |
| Stage2-vs-Stage4 |
5.601300E-04 |
| Stage3-vs-Stage4 |
2.253200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.94249999996288E-06 |
| Normal-vs-Asian |
1.14680487328656E-11 |
| Caucasian-vs-AfricanAmerican |
5.244000E-01 |
| Caucasian-vs-Asian |
8.094400E-01 |
| AfricanAmerican-vs-Asian |
7.240000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.208240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62536650805123E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.75959247172841E-12 |
| Normal-vs-Age(81-100Yrs) |
7.91400000000886E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.163800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.737200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.970000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.734400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.286000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.175000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.020200E-04 |
| Classical-VS-Follicular |
2.314000E-02 |
| Classical-VS-Other |
3.864400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.35960000000346E-06 |
| Tall-VS-Other |
5.027600E-01 |
| Tall-VS-Normal |
1.66533453693773E-15 |
| Follicular-VS-Other |
1.149190E-01 |
| Follicular-VS-Normal |
2.30630003983379E-09 |
| Other-VS-Normal |
1.382500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66533453693773E-15 |
| Normal-vs-N1 |
4.86388707088281E-13 |
| N0-vs-N1 |
1.504160E-01 |
|
|
